USANA Health Sciences (NYSE:USNA) Downgraded by Sidoti to Hold

Sidoti lowered shares of USANA Health Sciences (NYSE:USNA) from a strong-buy rating to a hold rating in a report published on Tuesday morning,Zacks.com reports.

A number of other brokerages have also recently commented on USNA. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. DA Davidson lifted their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd.

USANA Health Sciences Price Performance

Shares of NYSE:USNA opened at $31.16 on Tuesday. The company’s fifty day moving average price is $34.02 and its 200-day moving average price is $36.85. USANA Health Sciences has a one year low of $30.13 and a one year high of $50.32. The firm has a market capitalization of $593.99 million, a price-to-earnings ratio of 11.01, a PEG ratio of 0.85 and a beta of 0.87.

Hedge Funds Weigh In On USANA Health Sciences

Institutional investors and hedge funds have recently made changes to their positions in the business. Public Employees Retirement System of Ohio grew its position in USANA Health Sciences by 635.5% during the 4th quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company’s stock valued at $182,000 after purchasing an additional 4,385 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of USANA Health Sciences by 83.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 17,300 shares of the company’s stock valued at $621,000 after buying an additional 7,877 shares during the last quarter. Millennium Management LLC bought a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $633,000. Lazard Asset Management LLC raised its holdings in USANA Health Sciences by 24,765.5% in the 4th quarter. Lazard Asset Management LLC now owns 7,211 shares of the company’s stock worth $258,000 after acquiring an additional 7,182 shares during the last quarter. Finally, Jacobs Levy Equity Management Inc. lifted its position in USANA Health Sciences by 16.7% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 128,976 shares of the company’s stock valued at $4,629,000 after acquiring an additional 18,490 shares in the last quarter. Institutional investors own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.